Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hematopoietic Stem Cell Transplantation | 76 | 2024 | 5672 | 7.790 |
Why?
|
Anemia, Sickle Cell | 24 | 2024 | 1063 | 4.680 |
Why?
|
Graft vs Host Disease | 29 | 2024 | 3029 | 2.530 |
Why?
|
Fetal Hemoglobin | 9 | 2024 | 345 | 1.920 |
Why?
|
beta-Thalassemia | 5 | 2024 | 236 | 1.710 |
Why?
|
Homosexuality, Male | 13 | 2024 | 1334 | 1.680 |
Why?
|
Transplantation Conditioning | 19 | 2024 | 1590 | 1.670 |
Why?
|
Leukemia, Myeloid, Acute | 15 | 2024 | 3615 | 1.560 |
Why?
|
Sexual Partners | 7 | 2020 | 796 | 1.500 |
Why?
|
Transplantation, Homologous | 25 | 2024 | 4807 | 1.260 |
Why?
|
Hemophilia B | 2 | 2020 | 84 | 1.200 |
Why?
|
Heterocyclic Compounds | 4 | 2022 | 246 | 1.130 |
Why?
|
Hematopoietic Stem Cells | 9 | 2024 | 3397 | 1.070 |
Why?
|
Sexual Behavior | 7 | 2022 | 2180 | 1.000 |
Why?
|
Hemophilia A | 2 | 2020 | 360 | 0.980 |
Why?
|
Blood Component Removal | 2 | 2022 | 132 | 0.940 |
Why?
|
Hematologic Neoplasms | 8 | 2024 | 1896 | 0.910 |
Why?
|
HLA Antigens | 3 | 2024 | 1328 | 0.810 |
Why?
|
Stereotaxic Techniques | 1 | 2024 | 555 | 0.760 |
Why?
|
Transplants | 1 | 2023 | 206 | 0.730 |
Why?
|
Dyskeratosis Congenita | 1 | 2021 | 73 | 0.720 |
Why?
|
Isoantibodies | 1 | 2024 | 674 | 0.710 |
Why?
|
Electrodes, Implanted | 1 | 2024 | 840 | 0.660 |
Why?
|
Hepatitis, Autoimmune | 1 | 2021 | 172 | 0.650 |
Why?
|
Negotiating | 1 | 2020 | 150 | 0.620 |
Why?
|
HIV Infections | 13 | 2024 | 17352 | 0.610 |
Why?
|
Gonorrhea | 1 | 2022 | 346 | 0.610 |
Why?
|
Tetany | 1 | 2017 | 13 | 0.610 |
Why?
|
Fibrosis | 2 | 2024 | 2049 | 0.600 |
Why?
|
Plasma Cells | 1 | 2021 | 599 | 0.590 |
Why?
|
Splenectomy | 1 | 2019 | 391 | 0.590 |
Why?
|
Bone Marrow | 7 | 2023 | 2911 | 0.570 |
Why?
|
Sexually Transmitted Diseases | 2 | 2022 | 662 | 0.560 |
Why?
|
Tissue and Organ Harvesting | 1 | 2020 | 373 | 0.550 |
Why?
|
Self Care | 3 | 2019 | 796 | 0.540 |
Why?
|
Organ Preservation | 1 | 2020 | 382 | 0.540 |
Why?
|
Immunocompromised Host | 1 | 2021 | 857 | 0.530 |
Why?
|
Hypocalcemia | 1 | 2017 | 200 | 0.530 |
Why?
|
Humans | 124 | 2024 | 761572 | 0.520 |
Why?
|
Bone Marrow Transplantation | 3 | 2023 | 2693 | 0.510 |
Why?
|
Child | 40 | 2024 | 80156 | 0.510 |
Why?
|
Antigens, CD34 | 8 | 2024 | 658 | 0.500 |
Why?
|
Trust | 1 | 2020 | 530 | 0.480 |
Why?
|
Lung Transplantation | 2 | 2024 | 1310 | 0.470 |
Why?
|
Blood Transfusion | 2 | 2019 | 1301 | 0.470 |
Why?
|
Myelodysplastic Syndromes | 2 | 2021 | 1394 | 0.460 |
Why?
|
Erythrocytes | 1 | 2023 | 2413 | 0.450 |
Why?
|
Neuroblastoma | 2 | 2023 | 1250 | 0.450 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 | 2024 | 1551 | 0.450 |
Why?
|
Physicians | 2 | 2024 | 4591 | 0.440 |
Why?
|
AIDS Serodiagnosis | 3 | 2020 | 220 | 0.440 |
Why?
|
Young Adult | 28 | 2024 | 59255 | 0.400 |
Why?
|
Recurrence | 12 | 2024 | 8466 | 0.380 |
Why?
|
Adolescent | 30 | 2024 | 88324 | 0.380 |
Why?
|
Tissue and Organ Procurement | 1 | 2020 | 962 | 0.380 |
Why?
|
Patient Preference | 1 | 2019 | 924 | 0.380 |
Why?
|
Aviation | 1 | 2011 | 49 | 0.370 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 2 | 2023 | 263 | 0.360 |
Why?
|
Social Support | 2 | 2020 | 2171 | 0.360 |
Why?
|
Preventive Health Services | 1 | 2015 | 567 | 0.340 |
Why?
|
Stem Cell Transplantation | 1 | 2017 | 1600 | 0.320 |
Why?
|
Hypoglycemia | 1 | 2016 | 883 | 0.320 |
Why?
|
gamma-Globins | 4 | 2024 | 106 | 0.310 |
Why?
|
Electroencephalography | 1 | 2024 | 6237 | 0.310 |
Why?
|
Statistics as Topic | 1 | 2015 | 2358 | 0.310 |
Why?
|
Mass Screening | 5 | 2020 | 5428 | 0.310 |
Why?
|
Adult | 41 | 2024 | 221203 | 0.310 |
Why?
|
Tissue Donors | 5 | 2024 | 2332 | 0.300 |
Why?
|
Survivors | 7 | 2024 | 2371 | 0.300 |
Why?
|
Transplantation, Autologous | 4 | 2023 | 2115 | 0.300 |
Why?
|
Laparoscopy | 1 | 2019 | 2036 | 0.290 |
Why?
|
Male | 45 | 2024 | 360842 | 0.290 |
Why?
|
Health Services Accessibility | 2 | 2024 | 5440 | 0.290 |
Why?
|
Quality of Life | 7 | 2022 | 13367 | 0.280 |
Why?
|
Hematopoietic Stem Cell Mobilization | 3 | 2022 | 225 | 0.270 |
Why?
|
Benzylamines | 3 | 2022 | 247 | 0.270 |
Why?
|
Heart Transplantation | 1 | 2020 | 3233 | 0.260 |
Why?
|
Child, Preschool | 12 | 2024 | 42230 | 0.260 |
Why?
|
Antibodies, Monoclonal | 2 | 2024 | 9177 | 0.250 |
Why?
|
Practice Guidelines as Topic | 2 | 2024 | 7391 | 0.250 |
Why?
|
United States | 17 | 2024 | 72335 | 0.250 |
Why?
|
Biomedical Research | 1 | 2020 | 3429 | 0.230 |
Why?
|
Retrospective Studies | 21 | 2024 | 80646 | 0.230 |
Why?
|
Pneumocystis carinii | 1 | 2024 | 72 | 0.220 |
Why?
|
Hypoglycemic Agents | 1 | 2016 | 3085 | 0.220 |
Why?
|
Hemoglobin, Sickle | 1 | 2023 | 113 | 0.210 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2024 | 310 | 0.210 |
Why?
|
Hydroxyurea | 1 | 2024 | 284 | 0.210 |
Why?
|
Immunotherapy, Adoptive | 2 | 2024 | 1469 | 0.210 |
Why?
|
Fiducial Markers | 1 | 2024 | 132 | 0.210 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2024 | 242 | 0.210 |
Why?
|
Histocompatibility Testing | 1 | 2024 | 712 | 0.200 |
Why?
|
Leukapheresis | 1 | 2022 | 134 | 0.200 |
Why?
|
Adrenoleukodystrophy | 1 | 2024 | 143 | 0.200 |
Why?
|
Cord Blood Stem Cell Transplantation | 1 | 2024 | 305 | 0.190 |
Why?
|
Cardiomyopathies | 2 | 2024 | 1964 | 0.190 |
Why?
|
Graft Survival | 3 | 2022 | 3820 | 0.190 |
Why?
|
Thrombotic Microangiopathies | 1 | 2022 | 123 | 0.190 |
Why?
|
Serologic Tests | 2 | 2020 | 381 | 0.180 |
Why?
|
Female | 31 | 2024 | 392686 | 0.180 |
Why?
|
beta-Globins | 1 | 2021 | 111 | 0.180 |
Why?
|
Neoplasm Recurrence, Local | 10 | 2023 | 9280 | 0.180 |
Why?
|
Mycoses | 1 | 2023 | 386 | 0.170 |
Why?
|
Burkitt Lymphoma | 1 | 2022 | 335 | 0.170 |
Why?
|
Vascular System Injuries | 1 | 2023 | 246 | 0.170 |
Why?
|
Community Health Planning | 1 | 2020 | 164 | 0.170 |
Why?
|
Advisory Committees | 1 | 2024 | 787 | 0.170 |
Why?
|
Hematology | 1 | 2023 | 243 | 0.170 |
Why?
|
Neoplasms | 7 | 2024 | 22173 | 0.170 |
Why?
|
Emergency Medical Services | 1 | 2011 | 1923 | 0.170 |
Why?
|
Prognosis | 5 | 2024 | 29629 | 0.170 |
Why?
|
Telemedicine | 2 | 2020 | 3052 | 0.160 |
Why?
|
Cyclophosphamide | 5 | 2023 | 2220 | 0.160 |
Why?
|
Chromosome Deletion | 1 | 2024 | 1386 | 0.160 |
Why?
|
Mycophenolic Acid | 1 | 2021 | 349 | 0.160 |
Why?
|
Primary Graft Dysfunction | 1 | 2020 | 111 | 0.160 |
Why?
|
Research Design | 1 | 2015 | 6180 | 0.160 |
Why?
|
Reference Standards | 1 | 2022 | 1003 | 0.160 |
Why?
|
Infertility | 2 | 2024 | 654 | 0.160 |
Why?
|
Nucleotides | 1 | 2021 | 454 | 0.160 |
Why?
|
Disease-Free Survival | 4 | 2024 | 6815 | 0.150 |
Why?
|
Memory, Short-Term | 1 | 2024 | 982 | 0.150 |
Why?
|
Career Choice | 1 | 2024 | 756 | 0.150 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2021 | 269 | 0.140 |
Why?
|
Tacrolimus | 1 | 2021 | 733 | 0.140 |
Why?
|
Promoter Regions, Genetic | 3 | 2024 | 5790 | 0.140 |
Why?
|
Myeloproliferative Disorders | 1 | 2023 | 613 | 0.140 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2021 | 790 | 0.140 |
Why?
|
Chromosome Aberrations | 1 | 2024 | 1768 | 0.140 |
Why?
|
Survival Rate | 3 | 2021 | 12725 | 0.140 |
Why?
|
Fatty Liver | 1 | 2023 | 790 | 0.140 |
Why?
|
Internet | 2 | 2024 | 3093 | 0.140 |
Why?
|
Acute Disease | 3 | 2023 | 7237 | 0.140 |
Why?
|
Unsafe Sex | 1 | 2018 | 238 | 0.140 |
Why?
|
Germ Cells | 1 | 2020 | 634 | 0.130 |
Why?
|
Repressor Proteins | 3 | 2024 | 2986 | 0.130 |
Why?
|
Lymphoma, B-Cell | 1 | 2022 | 940 | 0.130 |
Why?
|
Bayes Theorem | 1 | 2024 | 2330 | 0.130 |
Why?
|
Survival Analysis | 3 | 2023 | 10090 | 0.130 |
Why?
|
Clinical Competence | 1 | 2011 | 4793 | 0.130 |
Why?
|
Adenine | 1 | 2021 | 987 | 0.130 |
Why?
|
Hypogonadism | 1 | 2021 | 798 | 0.120 |
Why?
|
Testicular Neoplasms | 1 | 2021 | 799 | 0.120 |
Why?
|
Infant | 7 | 2024 | 36192 | 0.120 |
Why?
|
Killer Cells, Natural | 1 | 2024 | 2201 | 0.120 |
Why?
|
Leukemia | 1 | 2023 | 1522 | 0.120 |
Why?
|
Central Nervous System Neoplasms | 1 | 2023 | 916 | 0.120 |
Why?
|
Interferon Type I | 1 | 2018 | 562 | 0.120 |
Why?
|
Antibodies | 1 | 2022 | 2418 | 0.120 |
Why?
|
Vaccines | 1 | 2023 | 844 | 0.120 |
Why?
|
Heroin Dependence | 1 | 2015 | 172 | 0.110 |
Why?
|
Research Personnel | 1 | 2019 | 588 | 0.110 |
Why?
|
Treatment Outcome | 9 | 2024 | 64684 | 0.110 |
Why?
|
Caregivers | 2 | 2023 | 2238 | 0.110 |
Why?
|
Middle Aged | 16 | 2024 | 220920 | 0.110 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2015 | 239 | 0.110 |
Why?
|
HIV Seropositivity | 1 | 2019 | 960 | 0.110 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2023 | 4016 | 0.110 |
Why?
|
Risk Reduction Behavior | 1 | 2020 | 1112 | 0.110 |
Why?
|
Bisexuality | 1 | 2015 | 294 | 0.100 |
Why?
|
Informed Consent | 1 | 2019 | 1008 | 0.100 |
Why?
|
Busulfan | 2 | 2024 | 258 | 0.100 |
Why?
|
Societies, Medical | 1 | 2024 | 3905 | 0.100 |
Why?
|
Lung Diseases | 1 | 2022 | 1909 | 0.100 |
Why?
|
Leukemia, T-Cell | 1 | 2011 | 101 | 0.100 |
Why?
|
Prisoners | 1 | 2015 | 314 | 0.100 |
Why?
|
Myocardium | 1 | 2024 | 4725 | 0.090 |
Why?
|
Remission Induction | 3 | 2022 | 2397 | 0.090 |
Why?
|
Chronic Disease | 5 | 2024 | 9319 | 0.090 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2011 | 117 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2023 | 2297 | 0.090 |
Why?
|
Whole-Body Irradiation | 2 | 2022 | 433 | 0.090 |
Why?
|
Indoles | 1 | 2018 | 1833 | 0.090 |
Why?
|
Pneumonia | 1 | 2022 | 2143 | 0.090 |
Why?
|
Risk Factors | 7 | 2024 | 74213 | 0.090 |
Why?
|
Patient Participation | 1 | 2019 | 1445 | 0.080 |
Why?
|
Graft Rejection | 1 | 2022 | 4446 | 0.080 |
Why?
|
Antigens, CD19 | 2 | 2022 | 424 | 0.080 |
Why?
|
Poverty | 1 | 2021 | 2698 | 0.080 |
Why?
|
Epilepsy | 1 | 2024 | 3290 | 0.080 |
Why?
|
Patient Care Team | 1 | 2020 | 2521 | 0.080 |
Why?
|
Immunotherapy | 1 | 2024 | 4652 | 0.080 |
Why?
|
Genomics | 1 | 2024 | 5821 | 0.080 |
Why?
|
Health Behavior | 1 | 2020 | 2644 | 0.080 |
Why?
|
Granulocyte Colony-Stimulating Factor | 2 | 2021 | 629 | 0.080 |
Why?
|
Risk | 1 | 2020 | 9610 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2023 | 4319 | 0.070 |
Why?
|
Mice | 7 | 2023 | 81533 | 0.070 |
Why?
|
Intestinal Mucosa | 1 | 2018 | 3032 | 0.070 |
Why?
|
Suicide, Attempted | 1 | 2016 | 1402 | 0.070 |
Why?
|
DNA | 1 | 2021 | 7213 | 0.070 |
Why?
|
Dendritic Cells | 2 | 2023 | 2747 | 0.070 |
Why?
|
Sex Factors | 1 | 2021 | 10553 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 36429 | 0.070 |
Why?
|
Terminal Care | 1 | 2019 | 1761 | 0.070 |
Why?
|
Georgia | 2 | 2018 | 185 | 0.070 |
Why?
|
Liver Diseases | 1 | 2015 | 1298 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12463 | 0.070 |
Why?
|
Escherichia coli | 1 | 2018 | 4217 | 0.070 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15843 | 0.070 |
Why?
|
Gene Expression Regulation | 2 | 2021 | 11904 | 0.070 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 26127 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2020 | 10212 | 0.060 |
Why?
|
Cohort Studies | 4 | 2022 | 41493 | 0.060 |
Why?
|
Communication | 1 | 2020 | 3873 | 0.060 |
Why?
|
Decision Making | 1 | 2019 | 3929 | 0.060 |
Why?
|
Pentamidine | 1 | 2024 | 44 | 0.060 |
Why?
|
Calcium | 1 | 2017 | 5722 | 0.060 |
Why?
|
Cell Communication | 1 | 2011 | 1657 | 0.060 |
Why?
|
Antisickling Agents | 1 | 2024 | 73 | 0.060 |
Why?
|
Animals | 8 | 2024 | 168467 | 0.060 |
Why?
|
Graft vs Leukemia Effect | 1 | 2024 | 121 | 0.060 |
Why?
|
Age Factors | 1 | 2021 | 18398 | 0.060 |
Why?
|
T-Lymphocytes | 3 | 2022 | 10194 | 0.060 |
Why?
|
Survival | 1 | 2024 | 161 | 0.060 |
Why?
|
Myeloablative Agonists | 1 | 2024 | 209 | 0.050 |
Why?
|
Interferon-gamma | 1 | 2011 | 3162 | 0.050 |
Why?
|
Complement Inactivating Agents | 1 | 2022 | 53 | 0.050 |
Why?
|
Multiple Myeloma | 1 | 2020 | 5146 | 0.050 |
Why?
|
Aged | 7 | 2024 | 169310 | 0.050 |
Why?
|
Diterpenes | 1 | 2022 | 171 | 0.050 |
Why?
|
Computer Simulation | 1 | 2015 | 6241 | 0.050 |
Why?
|
Disease Models, Animal | 4 | 2022 | 18253 | 0.050 |
Why?
|
Base Pairing | 1 | 2021 | 140 | 0.050 |
Why?
|
North America | 1 | 2024 | 1276 | 0.040 |
Why?
|
Stomach | 1 | 2004 | 696 | 0.040 |
Why?
|
Donor Selection | 1 | 2022 | 232 | 0.040 |
Why?
|
Research Report | 1 | 2023 | 367 | 0.040 |
Why?
|
Fertility | 1 | 2024 | 771 | 0.040 |
Why?
|
Base Sequence | 2 | 2021 | 12441 | 0.040 |
Why?
|
Antibiotic Prophylaxis | 1 | 2024 | 637 | 0.040 |
Why?
|
Hemoglobinopathies | 1 | 2019 | 99 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2022 | 20571 | 0.040 |
Why?
|
Transgenes | 1 | 2022 | 1010 | 0.040 |
Why?
|
Bacterial Translocation | 1 | 2018 | 73 | 0.040 |
Why?
|
Genome, Human | 2 | 2021 | 4425 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 13642 | 0.040 |
Why?
|
Lymphocyte Depletion | 1 | 2019 | 602 | 0.040 |
Why?
|
Siblings | 1 | 2022 | 825 | 0.040 |
Why?
|
Safe Sex | 1 | 2018 | 144 | 0.040 |
Why?
|
Cause of Death | 2 | 2021 | 3683 | 0.040 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2022 | 621 | 0.040 |
Why?
|
Europe | 1 | 2024 | 3422 | 0.040 |
Why?
|
Mutagenesis | 1 | 2021 | 1232 | 0.040 |
Why?
|
Pain | 2 | 2022 | 5073 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2024 | 7827 | 0.030 |
Why?
|
Secondary Prevention | 1 | 2023 | 1475 | 0.030 |
Why?
|
Gene Targeting | 1 | 2019 | 838 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2021 | 1008 | 0.030 |
Why?
|
Point Mutation | 1 | 2021 | 1595 | 0.030 |
Why?
|
Disease Progression | 2 | 2023 | 13510 | 0.030 |
Why?
|
Erythropoiesis | 1 | 2019 | 683 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2024 | 1664 | 0.030 |
Why?
|
Incidence | 2 | 2024 | 21355 | 0.030 |
Why?
|
Sequence Deletion | 1 | 2019 | 1494 | 0.030 |
Why?
|
Fetal Blood | 1 | 2022 | 1347 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2019 | 1869 | 0.030 |
Why?
|
Gender Identity | 1 | 2020 | 766 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2020 | 787 | 0.030 |
Why?
|
Risk-Taking | 1 | 2020 | 1038 | 0.030 |
Why?
|
RNA, Viral | 1 | 2022 | 2846 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 1935 | 0.030 |
Why?
|
Sulfonamides | 1 | 2022 | 1978 | 0.030 |
Why?
|
Cost of Illness | 1 | 2022 | 1936 | 0.030 |
Why?
|
Saccharomyces cerevisiae | 1 | 2023 | 2688 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2021 | 1589 | 0.020 |
Why?
|
Mice, Congenic | 1 | 2011 | 97 | 0.020 |
Why?
|
Transplantation, Isogeneic | 1 | 2011 | 248 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2021 | 15936 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2019 | 1436 | 0.020 |
Why?
|
Receptors, Interferon | 1 | 2011 | 116 | 0.020 |
Why?
|
Critical Care | 1 | 2024 | 2697 | 0.020 |
Why?
|
RNA | 1 | 2021 | 2726 | 0.020 |
Why?
|
Oxygen | 1 | 2022 | 4227 | 0.020 |
Why?
|
Vaccination | 1 | 2023 | 3384 | 0.020 |
Why?
|
Prospective Studies | 1 | 2015 | 54426 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2018 | 14416 | 0.020 |
Why?
|
Models, Immunological | 1 | 2011 | 513 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2021 | 1940 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5247 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4580 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39107 | 0.020 |
Why?
|
Risk Assessment | 2 | 2021 | 23996 | 0.020 |
Why?
|
Genotype | 1 | 2023 | 12990 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2023 | 5799 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2022 | 3530 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2023 | 9420 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 3801 | 0.020 |
Why?
|
Medicaid | 1 | 2021 | 2818 | 0.020 |
Why?
|
Public Health | 1 | 2020 | 2669 | 0.020 |
Why?
|
Cell Line | 1 | 2021 | 15601 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2011 | 1171 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2024 | 22176 | 0.020 |
Why?
|
Lung | 1 | 2024 | 10002 | 0.020 |
Why?
|
Databases, Factual | 1 | 2021 | 7967 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14607 | 0.020 |
Why?
|
Pilot Projects | 1 | 2018 | 8633 | 0.010 |
Why?
|
Body Mass Index | 1 | 2022 | 12954 | 0.010 |
Why?
|
Cytokines | 1 | 2018 | 7396 | 0.010 |
Why?
|
Models, Biological | 1 | 2019 | 9469 | 0.010 |
Why?
|
Transcription Factors | 1 | 2022 | 12129 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2011 | 5485 | 0.010 |
Why?
|
Necrosis | 1 | 2004 | 1611 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 12947 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2011 | 9541 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2011 | 3080 | 0.010 |
Why?
|
Brain | 1 | 2024 | 27120 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 58986 | 0.010 |
Why?
|
Mutation | 1 | 2019 | 30054 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2011 | 22172 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2004 | 26198 | 0.000 |
Why?
|